FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Unraveling the equine lymphocyte proteome: differential sept...
PloS one2014; 9(3); e91684; doi: 10.1371/journal.pone.0091684

Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis.

Abstract: Equine recurrent uveitis is a spontaneous, lymphocyte-driven autoimmune disease. It affects horses worldwide and presents with painful remitting-relapsing inflammatory attacks of inner eye structures eventually leading to blindness. Since lymphocytes are the key players in equine recurrent uveitis, we were interested in potential changes of their protein repertoire which may be involved in disease pathogenesis. To create a reference for differential proteome analysis, we first unraveled the equine lymphocyte proteome by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subsequently identified 352 protein spots. Next, we compared lymphocytes from ERU cases and healthy horses with a two-dimensional fluorescence difference in gel electrophoresis approach. With this technique, we identified seven differentially expressed proteins between conditions. One of the significantly lower expressed candidates, septin 7, plays a role in regulation of cell shape, motility and migration. Further analyses revealed T cells as the main cell type with decreased septin 7 abundance in equine recurrent uveitis. These findings point to a possible pathogenetic role of septin 7 in this sight-threatening disease.
Get Full Text
Publication Date: 2014-03-10 PubMed ID: 24614191PubMed Central: PMC3951111DOI: 10.1371/journal.pone.0091684Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the differences in protein expression within the immune cells of horses suffering from equine recurrent uveitis (ERU), an autoimmune disease that can lead to blindness, and healthy horses. In particular, the study found that the protein septin 7, which influences cell shape, movement and migration, was less prevalent in the immune cells of horses with ERU.

Study Purpose and Methods

  • The primary aim of this research was to ascertain the changes that occur in the protein repertoire of lymphocytes, which are crucial players in ERU. This was pursued with the hope of better understanding the pathogenesis, or the biological mechanism leading to the disease development, of ERU.
  • The researchers first established a reference for differential proteome analysis by revealing the equine lymphocyte proteome, using a technique known as two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and identifying 352 protein spots.
  • Having identified the baseline proteome, the scientists then compared the lymphocytes from ERU-afflicted horses and healthy horses using another method called two-dimensional fluorescence difference in gel electrophoresis.

Findings

  • Seven proteins were found to have different levels of expression between the ERU and healthy cases. The examination of these proteins could give insights into the alteration of the immune response in ERU.
  • Specifically, one of the proteins called septin 7, was found significantly less in ERU cases. Septin 7 is important in regulating a cell’s shape, its ability to move, and its migration. Lower levels of septin 7 were discovered mainly within the T cells of the immune system.

Implications

  • The researchers suggest that the lower abundance of septin 7 may play a key role in the development of ERU.
  • This new information could contribute significantly to the understanding of the molecular changes that occur in ERU, paving the way for the development of new treatments or preventative measures for this sight-threatening disease.

Cite This Article

APA
Degroote RL, Hauck SM, Amann B, Hirmer S, Ueffing M, Deeg CA. (2014). Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis. PLoS One, 9(3), e91684. https://doi.org/10.1371/journal.pone.0091684

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 9
Issue: 3
Pages: e91684

Researcher Affiliations

Degroote, Roxane L
  • Institute of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilians University Munich, Munich, Germany.
Hauck, Stefanie M
  • Research Unit Protein Sciences, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Amann, Barbara
  • Institute of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilians University Munich, Munich, Germany.
Hirmer, Sieglinde
  • Institute of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilians University Munich, Munich, Germany.
Ueffing, Marius
  • Research Unit Protein Sciences, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany; Center for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University of Tübingen, Tübingen, Germany.
Deeg, Cornelia A
  • Institute of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilians University Munich, Munich, Germany.

MeSH Terms

  • Animals
  • Blotting, Western
  • Electrophoresis, Gel, Two-Dimensional
  • Flow Cytometry
  • Horse Diseases / immunology
  • Horses / immunology
  • Lymphocyte Subsets / metabolism
  • Mass Spectrometry
  • Proteome / metabolism
  • Recurrence
  • Septins / metabolism
  • T-Lymphocytes / metabolism
  • Uveitis / immunology
  • Uveitis / veterinary

Conflict of Interest Statement

Competing Interests: The authors have declared that no competing interests exist.

References

This article includes 60 references
  1. Gilger BC, Michau TM. Equine recurrent uveitis: new methods of management. Vet Clin North Am Equine Pract 20: 417–427, vii.
    pubmed: 15271431
  2. Deeg CA, Reese S, Gerhards H, Wildner G, Kaspers B. The uveitogenic potential of retinal S-antigen in horses. Invest Ophthalmol Vis Sci 45: 2286–2292.
    pubmed: 15223807
  3. Deeg CA, Ehrenhofer M, Thurau SR, Reese S, Wildner G. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res 75: 127–133.
    pubmed: 12137758
  4. Gilger BC, Malok E, Cutter KV, Stewart T, Horohov DW. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet Immunol Immunopathol 71: 17–28.
    pubmed: 10522783
  5. Schwink KL. Equine uveitis. Vet Clin North Am Equine Pract 8: 557–574.
    pubmed: 1458329
  6. Deeg CA, Hauck SM, Amann B, Pompetzki D, Altmann F. Equine recurrent uveitis-a spontaneous horse model of uveitis. Ophthalmic Res 40: 151–153.
    pubmed: 18421230
  7. Deeg CA, Thurau SR, Gerhards H, Ehrenhofer M, Wildner G. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur J Immunol 32: 2598–2606.
    pubmed: 12207344
  8. Deeg CA, Pompetzki D, Raith AJ, Hauck SM, Amann B. Identification and functional validation of novel autoantigens in equine uveitis. Mol Cell Proteomics 5: 1462–1470.
    pubmed: 16690753
  9. Deeg CA, Raith AJ, Amann B, Crabb JW, Thurau SR. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol 2007: 39245.
    pmc: PMC2246040pubmed: 18317528
  10. Deeg CA, Amann B, Raith AJ, Kaspers B. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Invest Ophthalmol Vis Sci 47: 652–656.
    pubmed: 16431964
  11. Hauck SM, Dietter J, Kramer RL, Hofmaier F, Zipplies JK. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 9: 2292–2305.
    pmc: PMC2953921pubmed: 20601722
  12. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383–5392.
    pubmed: 12403597
  13. Tooley AJ, Gilden J, Jacobelli J, Beemiller P, Trimble WS. Amoeboid T lymphocytes require the septin cytoskeleton for cortical integrity and persistent motility. Nat Cell Biol 11: 17–26.
    pmc: PMC3777658pubmed: 19043408
  14. Spiess BM. Equine recurrent uveitis: the European viewpoint. Equine Vet J Suppl 50–56.
    pubmed: 20939167
  15. Fruhauf B, Ohnesorge B, Deegen E, Boeve M. Surgical management of equine recurrent uveitis with single port pars plana vitrectomy. Vet Ophthalmol 1: 137–151.
    pubmed: 11397223
  16. Gilger BC, Salmon JH, Wilkie DA, Cruysberg LP, Kim J. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci 47: 2596–2605.
    pubmed: 16723476
  17. LeHoang P, Sterkers M, Thillaye B, de Kozak Y, Coscas G. Primate model of uveoretinitis and vasculitis/experimental autoimmune uveoretinitis induced in cynomolgus monkeys by retinal s antigen. Ophthalmic Res 40: 181–188.
    pubmed: 18421236
  18. Wildner G, Diedrichs-Mohring M, Thurau SR. Rat models of autoimmune uveitis. Ophthalmic Res 40: 141–144.
    pubmed: 18421228
  19. de Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB. Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat. J Autoimmun 6: 587–599.
    pubmed: 7694588
  20. Caspi RR. Ocular autoimmunity: the price of privilege?. Immunol Rev 213: 23–35.
    pubmed: 16972894
  21. Vergara D, Chiriaco F, Acierno R, Maffia M. Proteomic map of peripheral blood mononuclear cells. Proteomics 8: 2045–2051.
    pubmed: 18491318
  22. Ramirez-Boo M, Garrido JJ, Ogueta S, Calvete JJ, Gomez-Diaz C. Analysis of porcine peripheral blood mononuclear cells proteome by 2-DE and MS: analytical and biological variability in the protein expression level and protein identification. Proteomics 6 Suppl 1 S215–225.
    pubmed: 16511813
  23. Lenchik NI, Desiderio DM, Gerling IC. Two-dimensional gel electrophoresis characterization of the mouse leukocyte proteome, using a tri-reagent for protein extraction. Proteomics 5: 2202–2209.
    pubmed: 15841495
  24. Haudek VJ, Slany A, Gundacker NC, Wimmer H, Drach J. Proteome maps of the main human peripheral blood constituents. J Proteome Res 8: 3834–3843.
    pubmed: 19580323
  25. Chae JI, Kim J, Lee SG, Koh MW, Jeon YJ. Quantitative proteomic analysis of pregnancy-related proteins from peripheral blood mononuclear cells during pregnancy in pigs. Anim Reprod Sci 134: 164–176.
    pubmed: 22917877
  26. Schulz M, Dotzlaw H, Mikkat S, Eggert M, Neeck G. Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis. J Proteome Res 6: 3752–3759.
    pubmed: 17705417
  27. Gerling IC, Singh S, Lenchik NI, Marshall DR, Wu J. New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol Cell Proteomics 5: 293–305.
    pubmed: 16227630
  28. Degroote RL, Hauck SM, Kremmer E, Amann B, Ueffing M. Altered expression of talin 1 in peripheral immune cells points to a significant role of the innate immune system in spontaneous autoimmune uveitis. J Proteomics 75: 4536–4544.
    pubmed: 22306886
  29. Degroote RL, Hauck SM, Treutlein G, Amann B, Frohlich KJ. Expression Changes and Novel Interaction Partners of Talin 1 in Effector Cells of Autoimmune Uveitis. J Proteome Res .
    pubmed: 24144192
  30. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl 77–100.
    pubmed: 11205159
  31. Carlton JG, Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316: 1908–1912.
    pubmed: 17556548
  32. Hashizume S, Kuroda K, Murakami H. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium. Biochim Biophys Acta 763: 377–382.
    pubmed: 6652116
  33. Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem 179: 481–487.
    pubmed: 2537213
  34. Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem Cell Biol 84: 303–311.
    pubmed: 16936801
  35. Pao LI, Badour K, Siminovitch KA, Neel BG. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu Rev Immunol 25: 473–523.
    pubmed: 17291189
  36. Eriksen KW, Woetmann A, Skov L, Krejsgaard T, Bovin LF. Deficient SOCS3 and SHP-1 expression in psoriatic T cells. J Invest Dermatol 130: 1590–1597.
    pubmed: 20130595
  37. Sampson MJ, Lovell RS, Craigen WJ. The murine voltage-dependent anion channel gene family. Conserved structure and function. J Biol Chem 272: 18966–18973.
    pubmed: 9228078
  38. Maldonado EN, Lemasters JJ. Warburg revisited: regulation of mitochondrial metabolism by voltage-dependent anion channels in cancer cells. J Pharmacol Exp Ther 342: 637–641.
    pmc: PMC3422523pubmed: 22700429
  39. Okunuki Y, Usui Y, Kezuka T, Hattori T, Masuko K. Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol Vis 14: 1094–1104.
    pmc: PMC2426731pubmed: 18552983
  40. Bonilha VL. Focus on molecules: ezrin. Exp Eye Res 84: 613–614.
    pubmed: 16616740
  41. Pore D, Parameswaran N, Matsui K, Stone MB, Saotome I. Ezrin Tunes the Magnitude of Humoral Immunity. J Immunol .
    pmc: PMC3808844pubmed: 24043890
  42. Weirich CS, Erzberger JP, Barral Y. The septin family of GTPases: architecture and dynamics. Nat Rev Mol Cell Biol 9: 478–489.
    pubmed: 18478031
  43. Hartwell LH. Genetic control of the cell division cycle in yeast. IV. Genes controlling bud emergence and cytokinesis. Exp Cell Res 69: 265–276.
    pubmed: 4950437
  44. Byers B, Goetsch L. A highly ordered ring of membrane-associated filaments in budding yeast. J Cell Biol 69: 717–721.
    pmc: PMC2109696pubmed: 773946
  45. Li S, Ou XH, Wei L, Wang ZB, Zhang QH. Septin 7 is required for orderly meiosis in mouse oocytes. Cell Cycle 11: 3211–3218.
    pmc: PMC3466520pubmed: 22895176
  46. Kremer BE, Adang LA, Macara IG. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 130: 837–850.
    pmc: PMC2085444pubmed: 17803907
  47. Kremer BE, Haystead T, Macara IG. Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol Biol Cell 16: 4648–4659.
    pmc: PMC1237071pubmed: 16093351
  48. Kinoshita M, Field CM, Coughlin ML, Straight AF, Mitchison TJ. Self- and actin-templated assembly of Mammalian septins. Dev Cell 3: 791–802.
    pubmed: 12479805
  49. Santos J, Cerveira N, Bizarro S, Ribeiro FR, Correia C. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes. Leuk Res .
    pubmed: 19748670
  50. Engidawork E, Gulesserian T, Fountoulakis M, Lubec G. Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience 122: 145–154.
    pubmed: 14596856
  51. Jia ZF, Huang Q, Kang CS, Yang WD, Wang GX. Overexpression of septin 7 suppresses glioma cell growth. J Neurooncol 98: 329–340.
    pubmed: 20035367
  52. Deeg CA, Kaspers B, Gerhards H, Thurau SR, Wollanke B. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci 42: 393–398.
    pubmed: 11157872
  53. Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res 42: 41–50.
    pmc: PMC2756228pubmed: 18629448
  54. Zipplies JK, Hauck SM, Schoeffmann S, Amann B, van der Meijden CH. Kininogen in autoimmune uveitis: decrease in peripheral blood stream versus increase in target tissue. Invest Ophthalmol Vis Sci 51: 375–382.
    pubmed: 19696180
  55. Wasik AA, Polianskyte-Prause Z, Dong MQ, Shaw AS, Yates JR 3rd. Septin 7 forms a complex with CD2AP and nephrin and regulates glucose transporter trafficking. Mol Biol Cell 23: 3370–3379.
    pmc: PMC3431928pubmed: 22809625
  56. Marko AJ, Miller RA, Kelman A, Frauwirth KA. Induction of glucose metabolism in stimulated T lymphocytes is regulated by mitogen-activated protein kinase signaling. PLoS One 5: e15425.
    pmc: PMC2978105pubmed: 21085672
  57. Finlay DK. Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases. Front Immunol 3: 247.
    pmc: PMC3413010pubmed: 22891069
  58. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: un amour impossible?. Electrophoresis 21: 1054–1070.
    pubmed: 10786880
  59. Lilley KS, Friedman DB. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 1: 401–409.
    pubmed: 15966837
  60. Nagaraj N, Lu A, Mann M, Wisniewski JR. Detergent-based but gel-free method allows identification of several hundred membrane proteins in single LC-MS runs. J Proteome Res 7: 5028–5032.
    pubmed: 18839980
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.